The goal of this project evaluate the efficacy of NiteCAPP in improving insomnia in a rural dementia caregiver sample (n of 100 caregiver and PWD dyads). We will measure both the short term (post-treatment) and long term (6 and 12 months) effects of the intervention on CG sleep, arousal, inflammation, health, mood, burden and cognitive function, and PWD sleep.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Completion
Timeframe: Single administration at 8 weeks
Adherence
Timeframe: Single administration at 8 weeks
Internet Intervention Utility Questionnaire
Timeframe: Single administration at 8 weeks
Satisfaction Survey
Timeframe: Single administration at 8 weeks
Insomnia Severity Index
Timeframe: Single administration at baseline, 8 weeks, 6 month and 12 follow up
Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Pain Intensity - Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Pain Unpleasantness - Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Wake After Sleep Onset - Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Sleep Onset Latency- Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Sleep Efficiency- Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Fatigue - Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Sleep and Pain Medication - Daily Electronic Sleep Diaries
Timeframe: Daily at baseline, 8 weeks, 6 month and 12 follow up
Change in Perceived Stress Scale
Timeframe: Single administration at baseline, 8 weeks, 6 month and 12 follow up
Change in Kingston Caregiver Stress Scale (KCSS)
Timeframe: Single administration at baseline, 8 weeks, 6 month and 12 follow up
Change in Dysfunctional Beliefs About Sleep (DBAS)
Timeframe: Single administration at baseline, 8 weeks, 6 month and 12 follow up
Change in Peripheral Arousal
Timeframe: Single administration at baseline, 8 weeks, 6 month and 12 follow up
Change in Inflammation
Timeframe: Single blood draw at baseline, 8 weeks, 6 month and 12 follow up
Change in Blood-based Biomarker Interleukin 6 IL-6)
Timeframe: Single blood draw at baseline, 8 weeks, 6 month and 12 follow up
Change in Blood-based Biomarker AβB42
Timeframe: Single blood draw at baseline, 8 weeks, 6 month and 12 follow up
Change in Blood-based Biomarker Tau
Timeframe: Single blood draw at baseline, 8 weeks, 6 month and 12 follow up